Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Form 8.3 - FENNER PLC

17 Apr 2018 11:35

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the β€œCode”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose FENNER PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 16 April 2018
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 25p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 3,953,769 2.04% 297,136 0.15%
(2) Cash-settled derivatives:
898 0.00% 3,514,172 1.81%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 3,954,667 2.04% 3,811,308 1.96%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
25p ordinary Purchase 323 6.0950 GBP
25p ordinary Purchase 51,089 6.0900 GBP
25p ordinary Sale 1 6.0950 GBP
25p ordinary Sale 29 6.1100 GBP
25p ordinary Sale 103 6.0954 GBP
25p ordinary Sale 191 6.1000 GBP
25p ordinary Sale 645 6.0902 GBP
25p ordinary Sale 1,556 6.0900 GBP
25p ordinary Sale 11,154 6.0888 GBP

(b) Cash-settled derivative transactions

Class of

Product Nature of dealing Number of Price per
relevant description reference unit
security securities
25p ordinary SWAP Long 11 6.0900 GBP
25p ordinary SWAP Long 224 6.0950 GBP
25p ordinary CFD Long 11,346 6.0881 GBP
25p ordinary CFD Short 323 6.0955 GBP
25p ordinary CFD Short 48,137 6.0904 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state β€œnone”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state β€œnone”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 17 Apr 2018
Contact name: ELISE TANG
Telephone number: 0207 1163001

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180417005847/en/

Copyright Business Wire 2018

Date   Source Headline
19th Aug 20147:00 amRNSDirectorate Change
6th Aug 20142:13 pmRNSDirector/PDMR Shareholding
6th Aug 201410:33 amRNSDirector/PDMR Shareholding
16th Jul 20147:00 amRNSInterim Management Statement
30th Jun 20143:06 pmRNSHolding(s) in Company
20th Jun 201412:40 pmRNSHolding(s) in Company
12th Jun 20147:00 amRNSCapital Markets Event
6th Jun 201411:20 amRNSDirector/PDMR Shareholding
5th Jun 20141:43 pmRNSDirector/PDMR Shareholding
30th May 20147:00 amRNSTrading Update
24th Apr 20144:10 pmRNSHolding(s) in Company
23rd Apr 20147:00 amRNSHalf Yearly Report
15th Apr 201412:17 pmRNSHolding(s) in Company
2nd Apr 20142:02 pmRNSHolding(s) in Company
13th Mar 20149:34 amRNSHolding(s) in Company
11th Mar 20147:00 amRNSPre-Close Trading Statement
5th Mar 20143:47 pmRNSHolding(s) in Company
3rd Mar 201410:49 amRNSBlocklisting Interim Review
20th Feb 20142:47 pmRNSHolding(s) in Company
4th Feb 20149:59 amRNSDirector/PDMR Shareholding
31st Jan 201412:28 pmRNSHolding(s) in Company
24th Jan 20142:40 pmRNSHolding(s) in Company
23rd Jan 201412:21 pmRNSHolding(s) in Company
17th Jan 20141:36 pmRNSResult of AGM
15th Jan 20147:00 amRNSInterim Management Statement
12th Dec 201310:49 amRNSDocuments Available for Inspection/Notice of AGM
29th Nov 20139:24 amRNSTotal Voting Rights
25th Nov 20139:16 amRNSDirector/PDMR Shareholding
21st Nov 20133:39 pmRNSDirector/PDMR Shareholding
14th Nov 201311:27 amRNSAdditional Listing
13th Nov 201310:15 amRNSAmendment
13th Nov 20137:00 amRNSFinal Results
8th Nov 20132:25 pmRNSHolding(s) in Company
21st Oct 20132:35 pmRNSHolding(s) in Company
27th Sep 20132:38 pmRNSHolding(s) in Company
10th Sep 20137:00 amRNSPre-close Trading Statement
2nd Sep 20132:01 pmRNSBlocklisting Interim Review
28th Aug 201311:35 amRNSHolding(s) in Company
22nd Aug 201312:16 pmRNSHolding(s) in Company
7th Aug 20134:35 pmRNSHolding(s) in Company
31st Jul 201312:38 pmRNSHolding(s) in Company
18th Jul 20137:00 amRNSInterim Management Statement
10th Jul 20139:21 amRNSHolding(s) in Company
9th Jul 20132:10 pmRNSHolding(s) in Company
5th Jul 20133:14 pmRNSHolding(s) in Company
21st Jun 201310:05 amRNSDirector/PDMR Shareholding
10th Jun 201310:50 amRNSDirector/PDMR Shareholding
5th Jun 201310:55 amRNSDirector/PDMR Shareholding
30th May 20132:33 pmRNSDirector/PDMR Shareholding
24th May 20133:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.